Analytics Deployment Lead - 18 Months secondment / Fixed Term Contract at AstraZeneca

Setup: Hybrid
Location: Macclesfield, England
Type: Full-time, Contract
Level: lead/mgmt
Posted: Sep 30, 2026

Description

AstraZeneca is hiring an Analytics Deployment Lead for an 18-month secondment or fixed-term contract in Macclesfield. The role leads the deployment, adoption, cutover, hypercare, and stabilisation of SAP analytics across multiple locations, initially supporting UK business sites. It requires significant technology or transformation delivery experience at Director or Senior Director level, analytics knowledge for finance or pharmaceutical operations, global pharmaceutical or regulated-industry experience, executive-level influence, and experience leading third-party suppliers. The posting was posted on 30-Sept-2026 and closed on 11-Oct-2026.

Required Skills

SAP analytics
Analytics
Change management
User adoption
Supplier leadership
Executive influence

Additional Information

Required Previous Experiences: Significant technology or transformation delivery experience at Director or Senior Director level
Analytics knowledge for finance or pharmaceutical operations
Experience building and delivering complex plans
Experience in a global pharmaceutical company or regulated industry
Executive-level presentation and influence in complex global environments
Experience delivering in a sophisticated technology landscape
Experience leading third-party suppliers
Experience supporting delivery teams through ongoing improvement
Proven track record delivering organisational change, business readiness, and user adoption for analytics transformations
Preferred Qualifications: Background in analytics related to ERP systems
Experience managing a large analytics portfolio
Understanding of large-scale change management and communications approaches
Translation Company Name: AstraZeneca

About AstraZeneca

AstraZeneca

biopharmaceutical10001+

AstraZeneca is a global, science-led biopharmaceutical business. Its innovative medicines are used by millions of patients worldwide. The company invests in transformative technologies and commercial execution to bring its medicines to patients around the globe and drive growth beyond 2030. Its pipeline includes 183 projects; the company also reported six key positive Phase III programmes and eight first approvals in major markets in the first half.

View full company profile